PMC:3245220 / 622-779 JSONTXT

Annnotations TAB JSON ListView MergeView

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T451","span":{"begin":85,"end":89},"obj":"P17252"},{"id":"T452","span":{"begin":147,"end":151},"obj":"P17252"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    bionlp-st-ge-2016-reference

    {"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T468","span":{"begin":92,"end":101},"obj":"Negative_regulation"},{"id":"T469","span":{"begin":92,"end":101},"obj":"Negative_regulation"},{"id":"T470","span":{"begin":111,"end":125},"obj":"Gene_expression"},{"id":"T480","span":{"begin":85,"end":89},"obj":"Protein"},{"id":"T491","span":{"begin":90,"end":91},"obj":"Protein"},{"id":"T494","span":{"begin":129,"end":151},"obj":"Protein"}],"relations":[{"id":"R411","pred":"themeOf","subj":"T480","obj":"T468"},{"id":"R415","pred":"themeOf","subj":"T491","obj":"T469"},{"id":"R417","pred":"themeOf","subj":"T494","obj":"T470"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    bionlp-st-ge-2016-reference-tees

    {"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T747","span":{"begin":15,"end":39},"obj":"Protein"},{"id":"T748","span":{"begin":41,"end":44},"obj":"Protein"},{"id":"T749","span":{"begin":85,"end":91},"obj":"Protein"},{"id":"T754","span":{"begin":111,"end":125},"obj":"Gene_expression"},{"id":"T755","span":{"begin":111,"end":125},"obj":"Gene_expression"},{"id":"T756","span":{"begin":111,"end":125},"obj":"Gene_expression"},{"id":"T757","span":{"begin":111,"end":125},"obj":"Gene_expression"}],"relations":[{"id":"R525","pred":"themeOf","subj":"T747","obj":"T754"},{"id":"R526","pred":"themeOf","subj":"T748","obj":"T755"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    events-check-again

    {"project":"events-check-again","denotations":[{"id":"T705","span":{"begin":85,"end":89},"obj":"Protein"},{"id":"T706","span":{"begin":90,"end":91},"obj":"Protein"},{"id":"T707","span":{"begin":92,"end":101},"obj":"Negative_regulation"},{"id":"T708","span":{"begin":92,"end":101},"obj":"Negative_regulation"},{"id":"T709","span":{"begin":111,"end":125},"obj":"Gene_expression"},{"id":"T710","span":{"begin":129,"end":151},"obj":"Protein"}],"relations":[{"id":"R501","pred":"themeOf","subj":"T705","obj":"T707"},{"id":"R502","pred":"themeOf","subj":"T706","obj":"T708"},{"id":"R503","pred":"themeOf","subj":"T710","obj":"T709"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T528","span":{"begin":41,"end":44},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T529","span":{"begin":85,"end":89},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T530","span":{"begin":147,"end":151},"obj":"http://purl.obolibrary.org/obo/GO_0004697"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T515","span":{"begin":41,"end":44},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T516","span":{"begin":85,"end":89},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T517","span":{"begin":147,"end":151},"obj":"http://purl.obolibrary.org/obo/GO_0004697"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    pmc-enju-pas

    {"project":"pmc-enju-pas","denotations":[{"id":"T335","span":{"begin":0,"end":3},"obj":"NN"},{"id":"T336","span":{"begin":4,"end":9},"obj":"CD"},{"id":"T337","span":{"begin":11,"end":14},"obj":"DT"},{"id":"T338","span":{"begin":15,"end":22},"obj":"JJ"},{"id":"T339","span":{"begin":23,"end":30},"obj":"NN"},{"id":"T340","span":{"begin":31,"end":37},"obj":"NN"},{"id":"T341","span":{"begin":38,"end":39},"obj":"NN"},{"id":"T342","span":{"begin":40,"end":41},"obj":"-LRB-"},{"id":"T343","span":{"begin":41,"end":44},"obj":"NN"},{"id":"T344","span":{"begin":44,"end":45},"obj":"-RRB-"},{"id":"T345","span":{"begin":46,"end":55},"obj":"NN"},{"id":"T346","span":{"begin":56,"end":66},"obj":"NN"},{"id":"T347","span":{"begin":66,"end":67},"obj":"-COMMA-"},{"id":"T348","span":{"begin":68,"end":71},"obj":"DT"},{"id":"T349","span":{"begin":72,"end":84},"obj":"JJ"},{"id":"T350","span":{"begin":85,"end":91},"obj":"NN"},{"id":"T351","span":{"begin":92,"end":101},"obj":"NN"},{"id":"T352","span":{"begin":102,"end":109},"obj":"NN"},{"id":"T353","span":{"begin":109,"end":110},"obj":"-COMMA-"},{"id":"T354","span":{"begin":111,"end":125},"obj":"NN"},{"id":"T355","span":{"begin":126,"end":128},"obj":"IN"},{"id":"T356","span":{"begin":129,"end":137},"obj":"JJ"},{"id":"T357","span":{"begin":138,"end":146},"obj":"JJ"},{"id":"T358","span":{"begin":147,"end":151},"obj":"NN"}],"relations":[{"id":"R301","pred":"arg1Of","subj":"T335","obj":"T336"},{"id":"R302","pred":"arg1Of","subj":"T341","obj":"T338"},{"id":"R303","pred":"arg1Of","subj":"T341","obj":"T339"},{"id":"R304","pred":"arg1Of","subj":"T341","obj":"T340"},{"id":"R305","pred":"arg1Of","subj":"T341","obj":"T342"},{"id":"R306","pred":"arg2Of","subj":"T343","obj":"T342"},{"id":"R307","pred":"arg3Of","subj":"T344","obj":"T342"},{"id":"R308","pred":"arg1Of","subj":"T346","obj":"T337"},{"id":"R309","pred":"arg1Of","subj":"T346","obj":"T341"},{"id":"R310","pred":"arg1Of","subj":"T346","obj":"T345"},{"id":"R311","pred":"arg1Of","subj":"T346","obj":"T347"},{"id":"R312","pred":"arg1Of","subj":"T346","obj":"T353"},{"id":"R313","pred":"arg2Of","subj":"T352","obj":"T347"},{"id":"R314","pred":"arg1Of","subj":"T352","obj":"T348"},{"id":"R315","pred":"arg1Of","subj":"T352","obj":"T349"},{"id":"R316","pred":"arg1Of","subj":"T352","obj":"T350"},{"id":"R317","pred":"arg1Of","subj":"T352","obj":"T351"},{"id":"R319","pred":"arg2Of","subj":"T354","obj":"T353"},{"id":"R320","pred":"arg1Of","subj":"T354","obj":"T355"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    bionlp-st-ge-2016-spacy-parsed

    {"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T142","span":{"begin":0,"end":3},"obj":"NNP"},{"id":"T143","span":{"begin":4,"end":9},"obj":"CD"},{"id":"T144","span":{"begin":9,"end":10},"obj":"."},{"id":"T145","span":{"begin":11,"end":14},"obj":"DT"},{"id":"T146","span":{"begin":15,"end":22},"obj":"JJ"},{"id":"T147","span":{"begin":23,"end":30},"obj":"NN"},{"id":"T148","span":{"begin":31,"end":37},"obj":"NN"},{"id":"T149","span":{"begin":38,"end":39},"obj":"NNP"},{"id":"T150","span":{"begin":40,"end":41},"obj":"-LRB-"},{"id":"T151","span":{"begin":41,"end":44},"obj":"NNP"},{"id":"T152","span":{"begin":44,"end":45},"obj":"-RRB-"},{"id":"T153","span":{"begin":46,"end":55},"obj":"NN"},{"id":"T154","span":{"begin":56,"end":66},"obj":"NN"},{"id":"T155","span":{"begin":66,"end":67},"obj":","},{"id":"T156","span":{"begin":68,"end":71},"obj":"DT"},{"id":"T157","span":{"begin":72,"end":84},"obj":"JJ"},{"id":"T158","span":{"begin":85,"end":89},"obj":"NNP"},{"id":"T159","span":{"begin":89,"end":90},"obj":"NN"},{"id":"T160","span":{"begin":90,"end":91},"obj":"NN"},{"id":"T161","span":{"begin":92,"end":101},"obj":"NN"},{"id":"T162","span":{"begin":102,"end":109},"obj":"NNP"},{"id":"T163","span":{"begin":109,"end":110},"obj":","},{"id":"T164","span":{"begin":111,"end":125},"obj":"NN"},{"id":"T165","span":{"begin":126,"end":128},"obj":"IN"},{"id":"T166","span":{"begin":129,"end":137},"obj":"JJ"},{"id":"T167","span":{"begin":138,"end":146},"obj":"JJ"},{"id":"T168","span":{"begin":147,"end":151},"obj":"NNP"}],"relations":[{"id":"R111","pred":"nummod","subj":"T143","obj":"T142"},{"id":"R113","pred":"det","subj":"T145","obj":"T147"},{"id":"R114","pred":"amod","subj":"T146","obj":"T147"},{"id":"R116","pred":"compound","subj":"T148","obj":"T149"},{"id":"R117","pred":"appos","subj":"T149","obj":"T147"},{"id":"R118","pred":"punct","subj":"T150","obj":"T149"},{"id":"R119","pred":"appos","subj":"T151","obj":"T149"},{"id":"R120","pred":"punct","subj":"T152","obj":"T149"},{"id":"R121","pred":"compound","subj":"T153","obj":"T154"},{"id":"R122","pred":"appos","subj":"T154","obj":"T149"},{"id":"R123","pred":"punct","subj":"T155","obj":"T149"},{"id":"R124","pred":"det","subj":"T156","obj":"T162"},{"id":"R125","pred":"amod","subj":"T157","obj":"T162"},{"id":"R126","pred":"compound","subj":"T158","obj":"T162"},{"id":"R127","pred":"compound","subj":"T159","obj":"T162"},{"id":"R128","pred":"compound","subj":"T160","obj":"T162"},{"id":"R129","pred":"compound","subj":"T161","obj":"T162"},{"id":"R130","pred":"appos","subj":"T162","obj":"T149"},{"id":"R131","pred":"punct","subj":"T163","obj":"T162"},{"id":"R132","pred":"appos","subj":"T164","obj":"T162"},{"id":"R133","pred":"prep","subj":"T165","obj":"T164"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}

    test2

    {"project":"test2","denotations":[{"id":"T31","span":{"begin":85,"end":89},"obj":"Protein"},{"id":"T32","span":{"begin":90,"end":91},"obj":"Protein"},{"id":"T33","span":{"begin":92,"end":101},"obj":"Negative_regulation"},{"id":"T34","span":{"begin":129,"end":151},"obj":"Protein"}],"relations":[{"id":"R18","pred":"themeOf","subj":"T31","obj":"T33"},{"id":"R19","pred":"themeOf","subj":"T32","obj":"T33"}],"text":"RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα const"}